Aminoadipic acid
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Aminoadipic acid
Description:
Aminoadipic acid is an orally active lysine oxide derivative. Aminoadipic acid induces ROS generation, increases free Ca2+, decreases SOD, and activates TXNIP/NLRP3 pathway. Aminoadipic acid has pro-inflammatory effects. Aminoadipic acid can be used in atherosclerosis research[1][2][3][4].Product Name Alternative:
YH439UNSPSC:
12352211Hazard Statement:
H317Target:
Calcium Channel; Endogenous Metabolite; NOD-like Receptor (NLR) ; Reactive Oxygen Species (ROS) ; SODType:
Natural ProductsRelated Pathways:
Immunology/Inflammation; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease; Neuronal Signaling; NF-κBApplications:
Metabolism-sugar/lipid metabolismField of Research:
Inflammation/Immunology; Cardiovascular DiseaseAssay Protocol:
https://www.medchemexpress.com/Aminoadipic_acid.htmlPurity:
99.86Solubility:
DMSO : 2 mg/mL (ultrasonic) |H2O : 2.86 mg/mL (ultrasonic)Smiles:
O=C(O)C(N)CCCC(O)=OMolecular Formula:
C6H11NO4Molecular Weight:
161.16Precautions:
H317References & Citations:
[1]Wang TJ, et al. 2-Aminoadipic acid is a biomarker for diabetes risk. J Clin Invest. 2013 Oct;123 (10) :4309-17.|[2]Wang X, et al. α-Aminoadipic acid protects against retinal disruption through attenuating Müller cell gliosis in a rat model of acute ocular hypertension. Drug Des Devel Ther. 2016 Oct 20;10:3449-3457.|[3]Estaras M, et al. The lysine derivative aminoadipic acid, a biomarker of protein oxidation and diabetes-risk, induces production of reactive oxygen species and impairs trypsin secretion in mouse pancreatic acinar cells. Food Chem Toxicol. 2020 Nov;145:111594.|[4]Wang T, et al. Aminoadipic acid aggravates atherosclerotic vascular inflammation through ROS/TXNIP/NLRP3 pathway, a harmful microbial metabolite reduced by paeonol. Int J Biochem Cell Biol. 2024 Dec;177:106678.Shipping Conditions:
Room TemperatureStorage Conditions:
4°C (Powder, protect from light)Scientific Category:
Natural ProductsClinical Information:
No Development ReportedIsoform:
Human Endogenous MetaboliteCAS Number:
[542-32-5]
